Webdisclosure.com

AURELIUS AG (FRA:AR4)

31/01/2023 14:02

EQS-Adhoc: Termination of stock exchange inclusion in Munich

Voir tous les communiqués de AURELIUS AG

AURELIUS AG (FRA:AR4)

26/01/2023 16:44

EQS-News: Notice according to Art. 2 (1) of the Delegated Regulation (EU) 2016/1052

Voir tous les communiqués de AURELIUS AG

AURELIUS AG (FRA:AR4)

23/01/2023 08:10

EQS-Adhoc: AURELIUS Equity Opportunities SE & Co. KGaA resolves retirement of 1,500,000 treasury shares and is starting the Share Buyback Program 2023 for an amount of up to EUR 30 million

Voir tous les communiqués de AURELIUS AG

AURELIUS AG (FRA:AR4)

16/01/2023 19:36

EQS-News: AURELIUS Equity Opportunities to seek segment change

Voir tous les communiqués de AURELIUS AG

AURELIUS AG (FRA:AR4)

16/01/2023 19:12

EQS-Adhoc: Application for termination of stock exchange inclusion in Munich

Voir tous les communiqués de AURELIUS AG

AURELIUS AG (FRA:AR4)

10/11/2022 07:30

EQS-News: AURELIUS Equity Opportunities reports results for the first nine months of 2022

Voir tous les communiqués de AURELIUS AG

AURELIUS AG (FRA:AR4)

11/10/2022 07:00

EQS-News: AURELIUS Equity Opportunities sells Briar Chemicals to Safex Chemicals

Voir tous les communiqués de AURELIUS AG

AURELIUS AG (FRA:AR4)

16/08/2022 07:30

AURELIUS sells operating business of Transform Hospital Group to Y1 Capital

Voir tous les communiqués de AURELIUS AG

AURELIUS AG (FRA:AR4)

11/08/2022 07:30

AURELIUS Equity Opportunities reports robust growth also in the first half of 2022 despite persistently tough economic conditions

Voir tous les communiqués de AURELIUS AG

AURELIUS AG (FRA:AR4)

30/06/2022 12:31

Notice according to Art. 2 (1) of the Delegated Regulation (EU) 2016/1052

Voir tous les communiqués de AURELIUS AG

1
2
3
4
5
6
7
8
9
10